Related Experiment Video
Updated: Jan 8, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Systemic Inertia in Addiction Care: Institutional Hesitancy and Ethical Barriers to Buprenorphine Initiation
Edicer Ramírez-Rivera1, Sofía Bravo-Torres1, Alana N Ortiz-Fraguada1
1Department of Psychiatry, University of Puerto Rico, Medical Sciences Campus, San Juan, PRI.
Systemic uncertainty and institutional anxiety delay essential medication for opioid use disorder (OUD) treatment. Achieving moral readiness for medication for OUD (MOUD) requires trust and clear procedures to prioritize patient well-being.
Area of Science:
- Medical Ethics
- Public Health Policy
- Addiction Medicine
Background:
- Opioid Use Disorder (OUD) treatment is hindered by institutional barriers.
- Medication for OUD (MOUD) implementation faces challenges due to systemic uncertainty and anxiety.
- Stigma and regulatory fears can impede evidence-based care for OUD.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Dependence
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Analgesia and Pain Management
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...

